Principal Securities, Inc. Innoviva, Inc. Call Options Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INVA
# of Institutions
284Shares Held
80.4MCall Options Held
10.3KPut Options Held
161K-
Black Rock Inc. New York, NY9.63MShares$163 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.18MShares$122 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$106 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.76MShares$80.6 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.29MShares$72.7 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.18B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...